The pandemic has led to a faster process in rolling out the right drug into the market, as pointed out by Umang Vohra, Global CEO & MD of Cipla.
In an exclusive conversation with Editorji and Fortune India, Vohra mentioned that data science and technology are allowing to match a prediction with the evidence really quickly.
"What took years to put together in terms of computational power, now just takes 10% of the time," Cipla's Global CEO told Editorji.